Patents
Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958)
04/2005
04/27/2005CN1198802C Chalcones having antiproliferactive activity
04/27/2005CN1198793C Ethers of methyl venlafaxine
04/26/2005CA2165830C Salmeterol xinafoate with controlled particle size
04/21/2005WO2005036275A1 Electrophotographic photoreceptor and image forming apparatus including the same
04/21/2005WO2005014525A3 Bi-aryl compound having immunosuppressive activity
04/21/2005US20050085524 Fungicides, bactericides, insecticides
04/21/2005US20050084943 New conditions for reactions mediated by yeast
04/21/2005US20050082231 reducing the aggregation and deposition of asphalts or bitumen from fluids such as crude oil, by adding to the fluids antideposit agents such as hexadecyl naphthoxide; reducing particle and/or soot emission during combustion of diesel fuel; pollution control
04/20/2005EP0916637B1 Process for preparating optically active compounds
04/20/2005CN1608055A Compounds for the treatment of metabolic disorders
04/20/2005CN1608049A Method for preparing benzyl cyanide compound
04/14/2005US20050080281 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom
04/13/2005EP1254104B1 Quaternary ammonium compounds and their use as anti-tussive agent
04/13/2005EP1031555B1 Difluoromethoxybenzene derivatives and their use as intermediates
04/13/2005CN1196464C Novel coloring agent for use in oxidative hair dyeing
04/12/2005US6878828 Coupling cysteine with benzonitrile, then esterifying, alkylating, hydrolyzing and reacting with acids to form 2-methylcysteine
04/12/2005US6878821 Modifying chemoselectivity during oxidation of nitrogen compounds
04/12/2005US6878750 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents
04/12/2005US6878732 5,7-diazaspiro(3.4)octane and -octene derivatives; treating diseases including emesis, depression, anxiety and cough
04/07/2005WO2004110364A9 Thiotungstate analogues and uses thereof
04/07/2005US20050075505 Reacting 3-(3,5-dimethylphenoxy)-2-hydroxypropylamine with such as ethyl chloroformate under alkaline conditions; high yield; reduced energy
04/07/2005US20050075394 Phenethanolamine derivatives for treatment of respiratory diseases
04/07/2005US20050075377 Compounds for elevating plasma lipid levels with prodrugs for humans and other mammals
04/07/2005US20050075332 Tricyclic compounds with antiviral activity
04/06/2005EP1520452A2 Electronic devices made with electron transport and/or anti-quenching layers
04/06/2005EP1520308A2 Polymeric charge transport compositions and electronic devices made with such compositions
04/06/2005EP1520305A2 Charge transport compositions and electronic devices made with such compositions
04/06/2005EP1519940A1 Substituted aryl boronic acids, their preparation and their precursors
04/06/2005EP1519935A2 Charge transport compositions comprising fluorinated phenanthroline derivatives
04/06/2005EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators
04/06/2005CN1604918A Monoamide based catalyst compositions for the polymerization of olefins
04/06/2005CN1604773A Treatment of faecal incontinence and other conditions with 1r, 2s-methoxamine
04/06/2005CN1603303A Preparation of N-methylated amines from selective vapor phase amination of amino ether alcohols
04/06/2005CN1195752C Processes for producing 7-isoindolinequinolonecarboxylic derivatives and intermediates therefor, solts of 7-isoindo-linequinolonecarboxylic acid, hydrates thereof, and composition contg. same
04/05/2005US6875883 Forming a phenyl-thiazoles chemical intermediates for making antioxidants, ferrielectric liquid crystal dopant, picornaviral viricides, antiinflammatory agents, anti-asthma agents, and fibringoen antagonists
04/05/2005US6875882 Ferroelectric liquid crystals, antihistamines, antiinflammatory agents, viricides
04/05/2005US6875850 Reagent for labelling nucleic acids
04/05/2005US6875775 Triphenylalkene derivatives and their use as selective estrogen receptor modulators
03/2005
03/31/2005WO2005028457A1 Preparation of quetiapine
03/31/2005DE10341533A1 Verfahren zur Herstellung von halogenhaltigen 4-Aminophenolen Process for the preparation of halogenated 4-aminophenols
03/30/2005EP1517881A1 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives
03/30/2005EP1517879A1 Aminoalkylphenols, methods of using and making the same
03/30/2005EP1296933B1 Self-reducible copper(ii) source reagents for chemical vapor deposition of copper metal
03/30/2005CN1602291A Novel bensophenone derivatives or salts thereof
03/30/2005CN1602184A Compounds for a controlled release of active molecules
03/29/2005US6872852 Polyamine analogues as cytotoxic agents
03/29/2005US6872741 Sodium channel modulators
03/24/2005WO2005025555A2 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid
03/24/2005WO2005000775A3 Cyclohexyl derivatives as selective estrogen receptor modulators
03/24/2005WO2004071426A3 Compounds for the treatment of viral infection
03/24/2005WO2004060882A8 Cb 1/cb 2 receptor ligands and their use in the treatment of pain
03/24/2005WO2004041896A8 Carbamate functional materials, a method of making said materials, and curable coating compositions containing said materials
03/23/2005EP1515940A2 Aminoalkoxy-functional chalcones
03/23/2005CN1599715A Venlafaxine hydrochloride monohydrate and methods for the preparation thereof
03/23/2005CN1193788C Beta 2-adrenergic receptor agonist
03/22/2005US6870070 Hydrogenation, resoulution, alkylation, bromination, andcarboxamidation
03/22/2005US6869904 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom
03/17/2005WO2005023744A2 Calixarenes as inhibitors of protein kinase b
03/17/2005WO2004087061A3 Tubulin binding agents and corresponding prodrug constructs
03/17/2005CA2538372A1 Calixarenes as inhibitors of protein kinase b
03/16/2005EP1514865A1 Process for the preparation of halogen containing 4-amino phenols
03/16/2005EP1513825A2 Anti tubercular drug: compositions and methods
03/16/2005EP1513795A2 Propionic acid derivatives and their use as hppars activators
03/16/2005CN1596248A Phenoxy amine compounds and compositions for delivering active agents
03/15/2005US6867310 Synthesize efficiently and under mild conditions alpha -aryl and alpha -vinyl products from a wide range of starting materials, including ketones, esters, hydrazones, and imines, enantiomorphs
03/15/2005US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency
03/10/2005WO2005000795A3 Aniline derivatived androgen-, glucocorticoid-, mineralcorticoid- and progesterone- receptor modulators
03/10/2005US20050054882 Diaryl ether condensation reactions
03/10/2005US20050054872 Hydrogenation of cyanoethylated alcohols, i.e. by reacting an alcohol with meth)acrylonitrile, utilizing an ether or amide solvent that solubilizes byproduct (meth)acrylonitrile and poly(meth)acrylonitrile present in the feedstock or produced during the hydrogenation; kinetics; durability of catalyst
03/10/2005US20050054641 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same
03/10/2005US20050052133 Bis(aminostyryl)naphthalene compound, synthesis intermediate thereof, and process for production thereof
03/09/2005EP1512675A1 Aminopropylation of alcohols in the presence of amide or ether solvents
03/09/2005EP1511716A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
03/09/2005EP1511473A2 Bis-aromatic alkanols
03/09/2005CN1590366A Improved method of preparing bisolol and its salt
03/09/2005CN1590357A Lightfast additive having uv-absorbing moiety and ink composition including the same
03/09/2005CN1192011C Calcium receptor-active arylalkyl amines
03/08/2005US6863211 Omega-hydrofluoroalkyl ethers, precursor carboxylic acids and derivatives thereof, and their preparation and application
03/03/2005WO2005019164A2 Preparation of phenethanolamine derivatives
03/03/2005WO2004101581A3 Nitrogen-containing monodentate phosphines and their use in catalysis
03/03/2005US20050049304 comprises the steps of preparing a mixture of venlafaxine with acetone then exposing the mixture to gaseous hydrochloric acid
03/02/2005EP1509497A1 Calcium receptor modulating arylalkylamines
03/02/2005EP1509495A1 Anilino liver x-receptor modulators
03/02/2005EP1509489A1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
03/02/2005EP1509222A1 Adduct of topiramate and tramadol hydrochloride and uses thereof
03/02/2005EP1509216A1 Active ingredient salts and esters of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and 3-(3-dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl)-phenol
03/02/2005EP1232279B1 Method for producing optically active amines
03/02/2005CN1587254A Separating device and method for dimethyl amino ethyl ether
03/02/2005CN1587252A Multiple photon absorptive phenyl fluorene derivative and its preparing method
03/02/2005CN1191230C Method for preparing neurainidase inhibitor RO-64-0796
03/01/2005US6861560 Bis-o-aminophenols and processes for producing bis-o-aminophenols
03/01/2005US6861532 Synthesis of 2-alkylcysteine
02/2005
02/24/2005WO2005016865A1 Gamma hydroxy carbamate compounds and methods of making and using the same
02/24/2005WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof
02/24/2005US20050043534 Modulators of ceramidase and methods of used based thereon
02/24/2005US20050043371 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
02/24/2005US20050043294 Treating atherosclerosis and other coronary artery diseases; preventing dyslipidemia
02/24/2005CA2535665A1 Substituted arylalkanoic acid derivative and use thereof
02/23/2005EP1507754A1 Alkoxy aryl beta-2 adrenergic receptor agonists
02/23/2005EP1507521A1 Metabolite of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentane-3-ol and the use thereof in the treatment of urinary incontinence
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 140